Pharmaceuticals sector

While You Were Sleeping: 5 stories you might have missed, Aug 3, 2026

Firefighters battle a wildfire near the Agia Paraskevi village, Greece, on Aug 2, 2026.

Pharma giants AstraZeneca, Bristol Myers Squibb in talks on $512 billion mega deal: Report

The report of the potential deal comes about a dozen years after AstraZeneca fended off a takeover attempt by larger US rival Pfizer.

India takes action against 90% of inspected high-risk pharmaceutical facilities: Regulator

The crackdown is part of a broader effort to strengthen quality standards in India after Indian-made cough syrups were linked by global health authorities to child deaths.

Johnson & Johnson reaches sweeping talc deal that could end decade of litigation

The settlement covers claims alleging that Johnson & Johnson’s talc products cause ovarian cancer.

US panel backs trendy peptides despite safety concerns

The peptides are popular in wellness circles but lack strong clinical evidence.

Trump plans 100% tariff on generic drugs from August 2028

Levies on drugs would double to 200 per cent in 2029, said the US president.

Japanese drugmaker Takeda’s Qdenga becomes first dengue vaccine approved in India

A government health worker collects blood sample from a patient at a dengue detention centre in Kolkata, India.

What to know about the powerful new cholesterol pill

FDA approves new pill to slash cholesterol levels

Lipfendra can lower cholesterol levels far below what can be achieved with statins.

China outpacing Europe in drug innovation and development: Pfizer executive

In 2024, of 81 innovative medicines launched, 28 came from China and only 18 came from Europe, said the Pfizer executive.

E-paper

Newsletters

Podcasts

RSS Feed

About Us

Terms & Conditions

Personal Data Protection Notice

Need help? Reach us here.

Advertise with us

MDDI (P) 046/10/2025. Published by SPH Media Limited, Co. Regn. No.202120748H. Copyright © 2026 SPH Media Limited. All rights reserved.